Medicis Extends Dysport(R) Challenge; Over 90% Chose "Love It"
May 26, 2010 08:00 ET
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz., May 26, 2010 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced 91.2% of patients who made a selection in the Dysport Challenge promoting Dysport (abobotulinumtoxinA) 300 Units...
Medicis Reports First Quarter 2010 Financial Results
May 05, 2010 16:05 ET
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz., May 5, 2010 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced revenues of approximately $166.5 million for the three months ended March 31, 2010, compared to revenues of...
Medicis Announces 2010 First Quarter Conference Call and Webcast
May 03, 2010 08:00 ET
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz., May 3, 2010 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced it expects to report 2010 first quarter financial results after the market closes on Wednesday, May 5, 2010....
Medicis to Present at Deutsche Bank Healthcare Conference
April 29, 2010 08:00 ET
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz., April 29, 2010 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced that the Company is scheduled to present at the Deutsche Bank 35th Annual Healthcare Conference in Boston,...
Medicis Extends the Popular DYSPORT(TM) Challenge by One Month
April 27, 2010 16:16 ET
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz., April 27, 2010 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced it has extended the "Dysport Challenge: Love It or Leave It" for Dysport (abobotulinumtoxinA) 300 Units for...
Medicis Announces Availability of Online Proxy Materials for 2010
April 06, 2010 08:00 ET
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz., April 6, 2010 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced that proxy materials are available via the Internet for its 2010 Annual Meeting of Stockholders under the U.S....
Medicis to Present at Roth OC Growth Stock Conference
March 12, 2010 08:00 ET
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz., March 12, 2010 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced that the Company is scheduled to present at the Roth 22nd Annual OC Growth Stock Conference in Laguna Niguel,...
Medicis Increases Cash Dividend to $0.06 Per Share
March 10, 2010 08:00 ET
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz., March 10, 2010 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced that its Board of Directors declared a quarter-end cash dividend of $0.06 per issued and outstanding share of...
Medicis to Present at Cowen and Company Health Care Conference
March 04, 2010 08:00 ET
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz., March 4, 2010 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced that the Company is scheduled to present at the Cowen and Company 30th Annual Health Care Conference in...
Medicis Presents the Dysport(TM) Challenge: Love It or Leave It
March 01, 2010 16:00 ET
|
Medicis Pharmaceutical Corporation
SCOTTSDALE, Ariz., March 1, 2010 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced the launch of its new program, the "Dysport Challenge." Approved by the U.S. Food and Drug Administration...